These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 27494844)

  • 1. Dose-dependent genotype effects of BDNF Val66Met polymorphism on default mode network in early stage Alzheimer's disease.
    Lin PH; Tsai SJ; Huang CW; Mu-En L; Hsu SW; Lee CC; Chen NC; Chang YT; Lan MY; Chang CC
    Oncotarget; 2016 Aug; 7(34):54200-54214. PubMed ID: 27494844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic effect of interleukin-1 beta (C-511T) polymorphism on the structural covariance network and white matter integrity in Alzheimer's disease.
    Huang CW; Hsu SW; Tsai SJ; Chen NC; Liu ME; Lee CC; Huang SH; Chang WN; Chang YT; Tsai WC; Chang CC
    J Neuroinflammation; 2017 Jan; 14(1):12. PubMed ID: 28100246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive and magnetic resonance imaging brain morphometric correlates of brain-derived neurotrophic factor Val66Met gene polymorphism in patients with schizophrenia and healthy volunteers.
    Ho BC; Milev P; O'Leary DS; Librant A; Andreasen NC; Wassink TH
    Arch Gen Psychiatry; 2006 Jul; 63(7):731-40. PubMed ID: 16818862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations of Bcl-2 rs956572 genotype groups in the structural covariance network in early-stage Alzheimer's disease.
    Chang CC; Chang YT; Huang CW; Tsai SJ; Hsu SW; Huang SH; Lee CC; Chang WN; Lui CC; Lien CY
    Alzheimers Res Ther; 2018 Feb; 10(1):17. PubMed ID: 29422088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catechol-O-Methyltransferase Val158Met Polymorphism on Striatum Structural Covariance Networks in Alzheimer's Disease.
    Chang CC; Tsai SJ; Chen NC; Huang CW; Hsu SW; Chang YT; Liu ME; Chang WN; Tsai WC; Lee CC
    Mol Neurobiol; 2018 Jun; 55(6):4637-4649. PubMed ID: 28707072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic effect of MTHFR C677T polymorphism on the structural covariance network and white-matter integrity in Alzheimer's disease.
    Chang YT; Hsu SW; Tsai SJ; Chang YT; Huang CW; Liu ME; Chen NC; Chang WN; Hsu JL; Lee CC; Chang CC
    Hum Brain Mapp; 2017 Jun; 38(6):3039-3051. PubMed ID: 28342207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of neural compensatory mechanisms of BDNF val66met met carriers and APOE E4 carriers in healthy aging, mild cognitive impairment, and Alzheimer's disease.
    Gomar JJ; Conejero-Goldberg C; Huey ED; Davies P; Goldberg TE;
    Neurobiol Aging; 2016 Mar; 39():165-73. PubMed ID: 26923413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BDNF Val66Met in preclinical Alzheimer's disease is associated with short-term changes in episodic memory and hippocampal volume but not serum mBDNF.
    Lim YY; Rainey-Smith S; Lim Y; Laws SM; Gupta V; Porter T; Bourgeat P; Ames D; Fowler C; Salvado O; Villemagne VL; Rowe CC; Masters CL; Zhou XF; Martins RN; Maruff P
    Int Psychogeriatr; 2017 Nov; 29(11):1825-1834. PubMed ID: 28720165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of the brain-derived neurotrophic factor and the apolipoprotein E polymorphisms on disease progression in preclinical Alzheimer's disease.
    Hashimoto R; Hirata Y; Asada T; Yamashita F; Nemoto K; Mori T; Moriguchi Y; Kunugi H; Arima K; Ohnishi T
    Genes Brain Behav; 2009 Feb; 8(1):43-52. PubMed ID: 18786162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuronal correlates of brain-derived neurotrophic factor Val66Met polymorphism and morphometric abnormalities in bipolar disorder.
    Matsuo K; Walss-Bass C; Nery FG; Nicoletti MA; Hatch JP; Frey BN; Monkul ES; Zunta-Soares GB; Bowden CL; Escamilla MA; Soares JC
    Neuropsychopharmacology; 2009 Jul; 34(8):1904-13. PubMed ID: 19295510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain derived neurotrophic factor Val66Met polymorphism and psychotic symptoms in Alzheimer's disease.
    Pivac N; Nikolac M; Nedic G; Mustapic M; Borovecki F; Hajnsek S; Presecki P; Pavlovic M; Mimica N; Muck Seler D
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):356-62. PubMed ID: 21044653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The BDNF Val66Met polymorphism, resting-state hippocampal functional connectivity and cognitive deficits in acute late-onset depression.
    Yin Y; Hou Z; Wang X; Sui Y; Yuan Y
    J Affect Disord; 2015 Sep; 183():22-30. PubMed ID: 26000753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of BDNF Val66Met functional polymorphism in Alzheimer's disease-related depression.
    Borroni B; Archetti S; Costanzi C; Grassi M; Ferrari M; Radeghieri A; Caimi L; Caltagirone C; Di Luca M; Padovani A;
    Neurobiol Aging; 2009 Sep; 30(9):1406-12. PubMed ID: 18179845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterizing the role of brain derived neurotrophic factor genetic variation in Alzheimer's disease neurodegeneration.
    Honea RA; Cruchaga C; Perea RD; Saykin AJ; Burns JM; Weinberger DR; Goate AM;
    PLoS One; 2013; 8(9):e76001. PubMed ID: 24086677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between BDNF polymorphism (Val66Met) and executive function in patients with amnestic mild cognitive impairment or mild Alzheimer disease.
    Nagata T; Shinagawa S; Nukariya K; Yamada H; Nakayama K
    Dement Geriatr Cogn Disord; 2012; 33(4):266-72. PubMed ID: 22699449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BDNF Val66Met, Aβ amyloid, and cognitive decline in preclinical Alzheimer's disease.
    Lim YY; Villemagne VL; Laws SM; Ames D; Pietrzak RH; Ellis KA; Harrington KD; Bourgeat P; Salvado O; Darby D; Snyder PJ; Bush AI; Martins RN; Masters CL; Rowe CC; Nathan PJ; Maruff P;
    Neurobiol Aging; 2013 Nov; 34(11):2457-64. PubMed ID: 23769397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of brain-derived neurotrophic factor Val66Met polymorphism on cognition and functional brain networks in patients with intractable partial epilepsy.
    Sidhu MK; Thompson PJ; Wandschneider B; Foulkes A; de Tisi J; Stretton J; Perona M; Thom M; Bonelli SB; Burdett J; Williams E; Duncan JS; Matarin M
    CNS Neurosci Ther; 2019 Feb; 25(2):223-232. PubMed ID: 29952080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between brain-derived neurotrophic factor (BDNF) gene polymorphisms and executive function in Japanese patients with Alzheimer's disease.
    Nagata T; Shinagawa S; Nukariya K; Ochiai Y; Kawamura S; Agawa-Ohta M; Kasahara H; Nakayama K; Yamada H
    Psychogeriatrics; 2011 Sep; 11(3):141-9. PubMed ID: 21951954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The brain-derived neurotrophic factor Val66Met polymorphism affects memory formation and retrieval of biologically salient stimuli.
    van Wingen G; Rijpkema M; Franke B; van Eijndhoven P; Tendolkar I; Verkes RJ; Buitelaar J; Fernández G
    Neuroimage; 2010 Apr; 50(3):1212-8. PubMed ID: 20097294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of association between the BDNF gene Val66Met polymorphism and Alzheimer disease in a Chinese Han population.
    He XM; Zhang ZX; Zhang JW; Zhou YT; Tang MN; Wu CB; Hong Z
    Neuropsychobiology; 2007; 55(3-4):151-5. PubMed ID: 17657167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.